康方生物公布三期临床试验积极结果:古莫替尼单抗治疗强直性脊柱炎和曼菲多昔单抗治疗特应性皮炎均达到主要终点

美股速递
Aug 25, 2025

康方生物公布三期临床试验积极结果:古莫替尼单抗治疗强直性脊柱炎和曼菲多昔单抗治疗特应性皮炎均达到主要终点

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10